(Q35552661)

8 August 2017

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis (English)

1 reference

https://api.crossref.org/works/10.1136/ARD.62.5.423

8 August 2017

1 reference

1 reference

1 reference

24 December 2023

1 reference

https://api.crossref.org/works/10.1136/ARD.62.5.423

24 December 2023

5

T. W J. Huizinga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

author name string

M. Hoekstra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

A. E. van Ede

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

C. J. Haagsma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

M. A F J. van de Laar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

M. W M. Kruijsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

R. F J M. Laan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

24 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

8 August 2017

https://ard.bmj.com/content/62/5/423.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

https://europepmc.org/articles/PMC1754533

24 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

https://europepmc.org/articles/PMC1754533?pdf=render

24 December 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

https://doi.org/10.1136/ard.62.5.423

24 December 2023

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12695153

https://syndication.highwire.org/content/doi/10.1136/ard.62.5.423

24 December 2023

1 reference

https://api.crossref.org/works/10.1136/ARD.62.5.423

Annals of the Rheumatic Diseases

24 December 2023

published in

1 reference

8 August 2017

62

1 reference

8 August 2017

5

1 reference

8 August 2017

423-426

1 reference

Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Prediction of creatinine clearance from serum creatinine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754533

The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis

26 September 2018

1 reference

12 December 2020

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis

1 reference

12 December 2020

Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group

1 reference

12 December 2020

Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis

1 reference

12 December 2020

Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy

1 reference

12 December 2020

Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid

1 reference

12 December 2020

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration

1 reference

12 December 2020

Concurrent use of folinic acid and methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Central nervous system toxicity associated with weekly low-dose methotrexate treatment

1 reference

12 December 2020

Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis

1 reference

12 December 2020

The effect of age on methotrexate efficacy and toxicity

1 reference

12 December 2020

Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Methotrexate--the relationship between dose and clinical effect

1 reference

12 December 2020

Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial

1 reference

12 December 2020

Adverse effects of low dose methotrexate therapy in rheumatoid arthritis

1 reference

12 December 2020

Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.62.5.423

1 reference

8 August 2017

1 reference

8 August 2017

1 reference